David A. Rosa, CEO and President at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC), bought 100,000 shares at $0.50 ($50K) on 2025-04-04, disclosed to the SEC on 2025-04-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |